Payment overview · 2025
General Payments
$650.03
30 reported records · 14 companies
Healthcare provider profile · identity verified
Michael Peter Dudenhoeffer, DO
Allopathic & Osteopathic Physicians|Family Medicine · JEFFERSON CITY, MO · NPI 1073517900
Verified facts
What the public records show
CMS Open Payments records show Michael Peter Dudenhoeffer, DO received $650.03 in general payments during 2025 across 30 reported records.
Axsome Therapeutics, Inc. accounted for 17.1% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 17 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Auvelity, Caplyta, Ingrezza, Jardiance, Kerendia, Mounjaro, Rexulti.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 74 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 47 claims for Symbicort by this doctor in 2024.
Axsome Therapeutics, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Auvelity as an associated drug or biological on 116023 records involving 35298 distinct recipient NPIs. Public Medicare Part D data also shows 11 claims for Auvelity by this doctor in 2024.
Bayer Healthcare Pharmaceuticals Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Kerendia as an associated drug or biological on 138674 records involving 48458 distinct recipient NPIs. Public Medicare Part D data also shows 52 claims for Kerendia by this doctor in 2024.
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported CAPLYTA as an associated drug or biological on 211855 records involving 46143 distinct recipient NPIs. Public Medicare Part D data also shows 30 claims for Caplyta by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 232 claims for Jardiance by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 117 claims for Mounjaro by this doctor in 2024.
Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 24 claims for Trulicity by this doctor in 2024.
Lundbeck LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 71829 records involving 25812 distinct recipient NPIs. Public Medicare Part D data also shows 72 claims for Rexulti by this doctor in 2024.
Neurocrine BioSciences, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported INGREZZA as an associated drug or biological on 126456 records involving 27390 distinct recipient NPIs. Public Medicare Part D data also shows 23 claims for Ingrezza by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Ozempic as an associated drug or biological on 261625 records involving 77793 distinct recipient NPIs. Public Medicare Part D data also shows 100 claims for Ozempic by this doctor in 2024.
Novo Nordisk Inc reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported Rybelsus as an associated drug or biological on 161257 records involving 55409 distinct recipient NPIs. Public Medicare Part D data also shows 26 claims for Rybelsus by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Axsome Therapeutics, Inc. | Unresolved — no canonical attribution shown | $111.13 | 17.1% | 5 | 2025 |
| Novo Nordisk Inc | Unresolved — no canonical attribution shown | $66.95 | 10.3% | 4 | 2025 |
| Corcept Therapeutics | Unresolved — no canonical attribution shown | $66.80 | 10.3% | 3 | 2025 |
| Aimmune Therapeutics, Inc. | Unresolved — no canonical attribution shown | $66.18 | 10.2% | 2 | 2025 |
| Lundbeck LLC | Unresolved — no canonical attribution shown | $57.03 | 8.8% | 2 | 2025 |
| Verona Pharma, Inc. | Unresolved — no canonical attribution shown | $55.80 | 8.6% | 3 | 2025 |
| Lilly USA, LLC | Unresolved — no canonical attribution shown | $43.61 | 6.7% | 2 | 2025 |
| Phathom Pharmaceuticals, Inc. | Unresolved — no canonical attribution shown | $42.35 | 6.5% | 2 | 2025 |
| Bayer Healthcare Pharmaceuticals Inc. | Unresolved — no canonical attribution shown | $39.74 | 6.1% | 2 | 2025 |
| Alkermes, Inc. | Unresolved — no canonical attribution shown | $23.47 | 3.6% | 1 | 2025 |
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $23.11 | 3.6% | 1 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $20.38 | 3.1% | 1 | 2025 |
| Eisai Inc. | Unresolved — no canonical attribution shown | $18.06 | 2.8% | 1 | 2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | Unresolved — no canonical attribution shown | $15.42 | 2.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $611.49 | 29 |
| Education | $38.54 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| Auvelity Normalized: auvelity |
Drug | Axsome Therapeutics, Inc. | $111.13 | 5 | 2025 |
Source payment records
|
|||||
| Korlym Normalized: korlym |
Drug | Corcept Therapeutics | $66.80 | 3 | 2025 |
Source payment records
|
|||||
| ZENPEP Normalized: zenpep |
Drug | Aimmune Therapeutics, Inc. | $66.18 | 2 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Lundbeck LLC | $57.03 | 2 | 2025 |
Source payment records
|
|||||
| Ohtuvayre Normalized: ohtuvayre |
Drug | Verona Pharma, Inc. | $55.80 | 3 | 2025 |
Source payment records
|
|||||
| Wegovy Normalized: wegovy |
Drug | Novo Nordisk Inc | $48.65 | 3 | 2025 |
Source payment records
|
|||||
| VOQUEZNA Normalized: voquezna |
Drug | Phathom Pharmaceuticals, Inc. | $42.35 | 2 | 2025 |
Source payment records
|
|||||
| Kerendia Normalized: kerendia |
Drug | Bayer Healthcare Pharmaceuticals Inc. | $39.74 | 2 | 2025 |
Source payment records
|
|||||
| ARISTADA Normalized: aristada |
Drug | Alkermes, Inc. | $23.47 | 1 | 2025 |
Source payment records
|
|||||
| LYBALVI Normalized: lybalvi |
Drug | Alkermes, Inc. | $23.47 | 1 | 2025 |
Source payment records
|
|||||
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $23.11 | 1 | 2025 |
Source payment records
|
|||||
| JARDIANCE Normalized: jardiance |
Drug | Lilly USA, LLC | $22.75 | 1 | 2025 |
Source payment records
|
|||||
| MOUNJARO Normalized: mounjaro |
Drug | Lilly USA, LLC | $20.86 | 1 | 2025 |
Source payment records
|
|||||
| ZEPBOUND Normalized: zepbound |
Drug | Lilly USA, LLC | $20.86 | 1 | 2025 |
Source payment records
|
|||||
| BREZTRI Normalized: breztri |
Drug | AstraZeneca Pharmaceuticals LP | $20.38 | 1 | 2025 |
Source payment records
|
|||||
| Leqembi Normalized: leqembi |
Drug | Eisai Inc. | $18.06 | 1 | 2025 |
Source payment records
|
|||||
| CAPLYTA Normalized: caplyta |
Drug | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $15.42 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| Auvelity auvelity |
2025 | Auvelity | 2024 | 11 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| CAPLYTA caplyta |
2025 | Caplyta | 2024 | 30 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| INGREZZA ingrezza |
2025 | Ingrezza | 2024 | 23 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| JARDIANCE jardiance |
2025 | Jardiance | 2024 | 232 | exact normalized | Medicare Part D |
| Kerendia kerendia |
2025 | Kerendia | 2024 | 52 Beneficiary count suppressed |
exact normalized | Medicare Part D |
| MOUNJARO mounjaro |
2025 | Mounjaro | 2024 | 117 | exact normalized | Medicare Part D |
| REXULTI rexulti |
2025 | Rexulti | 2024 | 72 | exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
74 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
47 | 12 |
| Axsome Therapeutics, Inc. Exact reporting entity; no affiliate inference |
2025 | Auvelity open payments reported associated product |
CMS Open Payments — General Payments 116023 supporting records · 35298 recipient NPIs · example record 1235293064 |
Auvelity · 2024 Exact normalized brand match · 1 Part D row |
11 | suppressed by CMS |
| Bayer Healthcare Pharmaceuticals Inc. Exact reporting entity; no affiliate inference |
2025 | Kerendia open payments reported associated product |
CMS Open Payments — General Payments 138674 supporting records · 48458 recipient NPIs · example record 1225434663 |
Kerendia · 2024 Exact normalized brand match · 1 Part D row |
52 | suppressed by CMS |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) Exact reporting entity; no affiliate inference |
2025 | CAPLYTA open payments reported associated product |
CMS Open Payments — General Payments 211855 supporting records · 46143 recipient NPIs · example record 1241243071 |
Caplyta · 2024 Exact normalized brand match · 1 Part D row |
30 | suppressed by CMS |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | JARDIANCE open payments reported associated product |
CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557 |
Jardiance · 2024 Exact normalized brand match · 1 Part D row |
232 | 38 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | MOUNJARO open payments reported associated product |
CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455 |
Mounjaro · 2024 Exact normalized brand match · 1 Part D row |
117 | 15 |
| Lilly USA, LLC Exact reporting entity; no affiliate inference |
2025 | TRULICITY open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601 |
Trulicity · 2024 Exact normalized brand match · 1 Part D row |
24 | suppressed by CMS |
| Lundbeck LLC Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 71829 supporting records · 25812 recipient NPIs · example record 1251759986 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
72 | 11 |
| Neurocrine BioSciences, Inc. Exact reporting entity; no affiliate inference |
2025 | INGREZZA open payments reported associated product |
CMS Open Payments — General Payments 126456 supporting records · 27390 recipient NPIs · example record 1242766729 |
Ingrezza · 2024 Exact normalized brand match · 1 Part D row |
23 | suppressed by CMS |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Ozempic open payments reported associated product |
CMS Open Payments — General Payments 261625 supporting records · 77793 recipient NPIs · example record 1188130076 |
Ozempic · 2024 Exact normalized brand match · 1 Part D row |
100 | 22 |
| Novo Nordisk Inc Exact reporting entity; no affiliate inference |
2025 | Rybelsus open payments reported associated product |
CMS Open Payments — General Payments 161257 supporting records · 55409 recipient NPIs · example record 1188130076 |
Rybelsus · 2024 Exact normalized brand match · 1 Part D row |
26 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Levothyroxine Sodium | Levothyroxine Sodium | 1103 | 195 |
| Furosemide | Furosemide | 1019 | 196 |
| Pantoprazole Sodium | Pantoprazole Sodium | 940 | 170 |
| Atorvastatin Calcium | Atorvastatin Calcium | 874 | 177 |
| Lisinopril | Lisinopril | 853 | 166 |
| Potassium Chloride | Potassium Chloride | 848 | 163 |
| Gabapentin | Gabapentin | 737 | 125 |
| Amlodipine Besylate | Amlodipine Besylate | 718 | 145 |
| Prednisone | Prednisone | 632 | 319 |
| Shingrix | Varicella-Zoster Ge/As01b/Pf | 601 | 453 |
| Eliquis | Apixaban | 542 | 62 |
| Tramadol Hcl | Tramadol Hcl | 519 | 93 |
| Sertraline Hcl | Sertraline Hcl | 511 | 86 |
| Metoprolol Tartrate | Metoprolol Tartrate | 501 | 92 |
| Metformin Hcl | Metformin Hcl | 490 | 98 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 427 | 90 |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 406 | 49 |
| Omeprazole | Omeprazole | 406 | 97 |
| Montelukast Sodium | Montelukast Sodium | 402 | 76 |
| Duloxetine Hcl | Duloxetine Hcl | 387 | 49 |
| Trazodone Hcl | Trazodone Hcl | 375 | 54 |
| Losartan Potassium | Losartan Potassium | 372 | 87 |
| Tamsulosin Hcl | Tamsulosin Hcl | 364 | 68 |
| Metoprolol Succinate | Metoprolol Succinate | 346 | 71 |
| Clonazepam | Clonazepam | 332 | 50 |
| Carvedilol | Carvedilol | 330 | 68 |
| Cephalexin | Cephalexin | 322 | 196 |
| Alprazolam | Alprazolam | 319 | 47 |
| Ropinirole Hcl | Ropinirole Hcl | 315 | 53 |
| Simvastatin | Simvastatin | 307 | 64 |
| Clopidogrel | Clopidogrel Bisulfate | 292 | 63 |
| Donepezil Hcl | Donepezil Hcl | 290 | 49 |
| Azithromycin | Azithromycin | 288 | 216 |
| Finasteride | Finasteride | 265 | 49 |
| Buspirone Hcl | Buspirone Hcl | 257 | 36 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 256 | 29 |
| Divalproex Sodium | Divalproex Sodium | 253 | 28 |
| Hydrochlorothiazide | Hydrochlorothiazide | 250 | 54 |
| Xarelto | Rivaroxaban | 243 | 34 |
| Quetiapine Fumarate | Quetiapine Fumarate | 241 | 39 |
| Allopurinol | Allopurinol | 233 | 52 |
| Lorazepam | Lorazepam | 233 | 46 |
| Jardiance | Empagliflozin | 232 | 38 |
| Famotidine | Famotidine | 229 | 40 |
| Memantine Hcl | Memantine Hcl | 227 | 39 |
| Mirtazapine | Mirtazapine | 225 | 44 |
| Fluoxetine Hcl | Fluoxetine Hcl | 190 | 29 |
| Escitalopram Oxalate | Escitalopram Oxalate | 188 | 29 |
| Baclofen | Baclofen | 182 | 27 |
| Meloxicam | Meloxicam | 181 | 38 |
| Citalopram Hbr | Citalopram Hydrobromide | 180 | 29 |
| Levofloxacin | Levofloxacin | 177 | 119 |
| Levetiracetam | Levetiracetam | 175 | 27 |
| Hydralazine Hcl | Hydralazine Hcl | 172 | 38 |
| Warfarin Sodium | Warfarin Sodium | 169 | 15 |
| Glipizide | Glipizide | 166 | 30 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 163 | 43 |
| Bupropion Hcl | Bupropion Hcl | 162 | 29 |
| Topiramate | Topiramate | 162 | 16 |
| Boostrix Tdap | Diphth,pertuss(Acell),tet Vac | 161 | 160 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 159 | 56 |
| Fluconazole | Fluconazole | 158 | 88 |
| Clonidine Hcl | Clonidine Hcl | 150 | 27 |
| Diazepam | Diazepam | 144 | 27 |
| Nifedipine Er | Nifedipine | 143 | 23 |
| Pravastatin Sodium | Pravastatin Sodium | 137 | 25 |
| Celecoxib | Celecoxib | 135 | 29 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 132 | 70 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 125 | 35 |
| Prazosin Hcl | Prazosin Hcl | 121 | 13 |
| Olanzapine | Olanzapine | 118 | 16 |
| Mounjaro | Tirzepatide | 117 | 15 |
| Invega Sustenna | Paliperidone Palmitate | 116 | 11 |
| Fentanyl | Fentanyl | 114 | 13 |
| Glimepiride | Glimepiride | 111 | 21 |
| Gentamicin Sulfate | Gentamicin Sulfate | 110 | 81 |
| Tizanidine Hcl | Tizanidine Hcl | 109 | 30 |
| Doxycycline Hyclate | Doxycycline Hyclate | 106 | 77 |
| Oxycodone Hcl | Oxycodone Hcl | 106 | 24 |
| Linzess | Linaclotide | 101 | 18 |
| Ozempic | Semaglutide | 100 | 22 |
| Atenolol | Atenolol | 99 | 19 |
| Nystatin | Nystatin | 99 | 44 |
| Paroxetine Hcl | Paroxetine Hcl | 92 | 19 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 91 | 17 |
| Risperidone | Risperidone | 91 | 15 |
| Ondansetron Hcl | Ondansetron Hcl | 90 | 43 |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 88 | 13 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 87 | 17 |
| Benztropine Mesylate | Benztropine Mesylate | 87 | 12 |
| Zolpidem Tartrate | Zolpidem Tartrate | 86 | 20 |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 82 | 53 |
| Bupropion Xl | Bupropion Hcl | 81 | 13 |
| Spironolactone | Spironolactone | 81 | 20 |
| Aripiprazole | Aripiprazole | 79 | 11 |
| Amitriptyline Hcl | Amitriptyline Hcl | 78 | suppressed |
| Lovastatin | Lovastatin | 78 | 12 |
| Myrbetriq | Mirabegron | 77 | suppressed |
| Farxiga | Dapagliflozin Propanediol | 74 | suppressed |
| Benazepril Hcl | Benazepril Hcl | 72 | 15 |
| Methotrexate | Methotrexate Sodium | 72 | suppressed |
| Rexulti | Brexpiprazole | 72 | 11 |
| Januvia | Sitagliptin Phosphate | 71 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 70 | 36 |
| Glyburide | Glyburide | 70 | 20 |
| Fluticasone Propionate | Fluticasone Propionate | 69 | 21 |
| Colchicine | Colchicine | 66 | 16 |
| Cholestyramine | Cholestyramine (With Sugar) | 65 | 15 |
| Propranolol Hcl | Propranolol Hcl | 65 | 13 |
| Pregabalin | Pregabalin | 63 | 14 |
| Albuterol Sulfate | Albuterol Sulfate | 62 | 24 |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 62 | 15 |
| Carbamazepine | Carbamazepine | 60 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 59 | 19 |
| Bumetanide | Bumetanide | 59 | 14 |
| Diclofenac Sodium | Diclofenac Sodium | 59 | 12 |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 59 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 59 | 19 |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 57 | suppressed |
| Cefdinir | Cefdinir | 56 | 46 |
| Ceftriaxone | Ceftriaxone Sodium | 56 | 35 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 56 | 34 |
| Nebivolol Hcl | Nebivolol Hcl | 55 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 54 | 13 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 53 | 12 |
| Venlafaxine Hcl | Venlafaxine Hcl | 53 | 11 |
| Alendronate Sodium | Alendronate Sodium | 52 | suppressed |
| Kerendia | Finerenone | 52 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 52 | 18 |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 52 | 12 |
| Lamotrigine | Lamotrigine | 51 | suppressed |
| Sotalol | Sotalol Hcl | 51 | 13 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 51 | 33 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 50 | 11 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 50 | 18 |
| Ssd | Silver Sulfadiazine | 50 | 24 |
| Metronidazole | Metronidazole | 49 | 37 |
| Probenecid-Colchicine | Probenecid/Colchicine | 49 | 11 |
| Morphine Sulfate Er | Morphine Sulfate | 48 | suppressed |
| Ondansetron Odt | Ondansetron | 48 | 16 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 47 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 47 | 12 |
| Valacyclovir | Valacyclovir Hcl | 47 | 17 |
| Amantadine | Amantadine Hcl | 46 | suppressed |
| Dexlansoprazole Dr | Dexlansoprazole | 46 | suppressed |
| Glipizide Er | Glipizide | 46 | suppressed |
| Levemir Flexpen | Insulin Detemir | 46 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 46 | 12 |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 46 | suppressed |
| Gemtesa | Vibegron | 45 | suppressed |
| Digoxin | Digoxin | 44 | suppressed |
| Ketoconazole | Ketoconazole | 44 | 15 |
| Latanoprost | Latanoprost | 43 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 42 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 41 | suppressed |
| Torsemide | Torsemide | 40 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 39 | suppressed |
| Amoxicillin | Amoxicillin | 38 | 16 |
| Doxazosin Mesylate | Doxazosin Mesylate | 38 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 37 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 37 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 37 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 36 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 36 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 35 | suppressed |
| Gemfibrozil | Gemfibrozil | 34 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 34 | suppressed |
| Pitavastatin Calcium | Pitavastatin Calcium | 34 | suppressed |
| Repatha Sureclick | Evolocumab | 34 | suppressed |
| Lansoprazole | Lansoprazole | 33 | suppressed |
| Novolog Flexpen | Insulin Aspart | 33 | 11 |
| Nystop | Nystatin | 33 | 16 |
| Paliperidone Er | Paliperidone | 33 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 32 | 32 |
| Morphine Sulfate | Morphine Sulfate | 32 | suppressed |
| Timolol Maleate | Timolol Maleate | 32 | suppressed |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 31 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 31 | 24 |
| Mupirocin | Mupirocin | 31 | 12 |
| Nabumetone | Nabumetone | 31 | suppressed |
| Synthroid | Levothyroxine Sodium | 31 | suppressed |
| Temazepam | Temazepam | 31 | suppressed |
| Anastrozole | Anastrozole | 30 | suppressed |
| Breo Ellipta | Fluticasone/Vilanterol | 30 | suppressed |
| Caplyta | Lumateperone Tosylate | 30 | suppressed |
| Ibuprofen | Ibuprofen | 30 | suppressed |
| Methylprednisolone | Methylprednisolone | 30 | 23 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 29 | suppressed |
| Breztri Aerosphere | Budesonide/Glycopyr/Formoterol | 29 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 29 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 29 | suppressed |
| Phenobarbital | Phenobarbital | 29 | suppressed |
| Silver Sulfadiazine | Silver Sulfadiazine | 29 | 14 |
| Cilostazol | Cilostazol | 28 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 28 | suppressed |
| Haloperidol | Haloperidol | 28 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 28 | suppressed |
| Techlite Pen Needle | Pen Needle, Diabetic | 28 | suppressed |
| Creon | Lipase/Protease/Amylase | 27 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 27 | suppressed |
| Dexamethasone Sodium Phosphate | Dexamethasone Sodium Phosphate | 26 | 17 |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 26 | suppressed |
| Lubiprostone | Lubiprostone | 26 | suppressed |
| Rybelsus | Semaglutide | 26 | suppressed |
| Sucralfate | Sucralfate | 26 | suppressed |
| Tolterodine Tartrate | Tolterodine Tartrate | 26 | suppressed |
| Bupropion Hcl Sr | Bupropion Hcl | 25 | suppressed |
| Dulera | Mometasone/Formoterol | 25 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 25 | suppressed |
| Acyclovir | Acyclovir | 24 | suppressed |
| Dextroamphetamine-Amphetamine | Dextroamphetamine/Amphetamine | 24 | suppressed |
| Fluphenazine Hcl | Fluphenazine Hcl | 24 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 24 | suppressed |
| Klor-Con M20 | Potassium Chloride | 24 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 24 | 12 |
| Trulicity | Dulaglutide | 24 | suppressed |
| Ingrezza | Valbenazine Tosylate | 23 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 23 | suppressed |
| Verapamil Er | Verapamil Hcl | 23 | suppressed |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 22 | suppressed |
| Indomethacin | Indomethacin | 22 | suppressed |
| Insulin Lispro | Insulin Lispro | 22 | suppressed |
| Methylphenidate Hcl | Methylphenidate Hcl | 22 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 22 | suppressed |
| Aspirin-Dipyridamole Er | Aspirin/Dipyridamole | 21 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 21 | suppressed |
| Entresto | Sacubitril/Valsartan | 21 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 21 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 21 | suppressed |
| Hydrocortisone | Hydrocortisone | 20 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 20 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 19 | suppressed |
| Clobetasol Propionate | Clobetasol Propionate | 19 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 19 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 19 | suppressed |
| Ezetimibe | Ezetimibe | 19 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 19 | suppressed |
| Minocycline Hcl | Minocycline Hcl | 19 | suppressed |
| Premarin | Estrogens, Conjugated | 19 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 18 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 18 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 18 | suppressed |
| Penicillin V Potassium | Penicillin V Potassium | 18 | suppressed |
| Primidone | Primidone | 18 | suppressed |
| Bisoprolol-Hydrochlorothiazide | Bisoprolol/Hydrochlorothiazide | 17 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 17 | suppressed |
| Folic Acid | Folic Acid | 16 | suppressed |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 16 | suppressed |
| Namzaric | Memantine Hcl/Donepezil Hcl | 16 | suppressed |
| Risperidone Er | Risperidone Microspheres | 16 | suppressed |
| Vilazodone Hcl | Vilazodone Hcl | 16 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 15 | suppressed |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 15 | suppressed |
| Metolazone | Metolazone | 15 | suppressed |
| Risperdal Consta | Risperidone Microspheres | 15 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 15 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 15 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 15 | suppressed |
| Vraylar | Cariprazine Hcl | 15 | suppressed |
| Desmopressin Acetate | Desmopressin Acetate | 14 | suppressed |
| Janumet Xr | Sitagliptin Phos/Metformin Hcl | 14 | suppressed |
| Methocarbamol | Methocarbamol | 14 | suppressed |
| Minoxidil | Minoxidil | 14 | suppressed |
| Nitroglycerin | Nitroglycerin | 14 | 12 |
| Pentoxifylline | Pentoxifylline | 14 | suppressed |
| Probenecid | Probenecid | 14 | suppressed |
| Belbuca | Buprenorphine Hcl | 13 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 13 | suppressed |
| Buprenorphine | Buprenorphine | 13 | suppressed |
| Clindamycin Hcl | Clindamycin Hcl | 13 | 12 |
| Dutasteride | Dutasteride | 13 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 13 | suppressed |
| Lacosamide | Lacosamide | 13 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 13 | suppressed |
| Loperamide | Loperamide Hcl | 13 | suppressed |
| Neupro | Rotigotine | 13 | suppressed |
| Twinrix | Hepatitis A And B Vaccine/Pf | 13 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 13 | suppressed |
| Ziprasidone Hcl | Ziprasidone Hcl | 13 | suppressed |
| Belsomra | Suvorexant | 12 | suppressed |
| Carisoprodol | Carisoprodol | 12 | suppressed |
| Incruse Ellipta | Umeclidinium Bromide | 12 | suppressed |
| Invokana | Canagliflozin | 12 | suppressed |
| Lamotrigine Er | Lamotrigine | 12 | suppressed |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 12 | suppressed |
| Methadone Hcl | Methadone Hcl | 12 | suppressed |
| Methazolamide | Methazolamide | 12 | suppressed |
| Naproxen | Naproxen | 12 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 12 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 12 | suppressed |
| Otezla | Apremilast | 12 | suppressed |
| Propranolol Hcl Er | Propranolol Hcl | 12 | suppressed |
| Santyl | Collagenase Clostridium Hist. | 12 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 12 | suppressed |
| Sulfasalazine | Sulfasalazine | 12 | suppressed |
| Valsartan | Valsartan | 12 | suppressed |
| Auvelity | Dextromethorphan Hbr/Bupropion | 11 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 11 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 11 | suppressed |
| Niacin Er | Niacin | 11 | suppressed |
| Olanzapine Odt | Olanzapine | 11 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 11 | suppressed |
| Ramipril | Ramipril | 11 | suppressed |
| Verapamil Sr | Verapamil Hcl | 11 | suppressed |
| Xopenex Hfa | Levalbuterol Tartrate | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $650.03 · 30 records | Axsome Therapeutics, Inc. | ARISTADA, Auvelity, BREZTRI, CAPLYTA, INGREZZA, JARDIANCE, Kerendia, Korlym, LYBALVI, Leqembi, MOUNJARO, Ohtuvayre, REXULTI, VOQUEZNA, Wegovy, ZENPEP, ZEPBOUND | 12 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Auvelity play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error